By comparing the six common criteria, including IPSS, MFR, AFR, residual volume, QOL, volume of the prostate, we found that tamsulosin is better than terazosin at improving IPSSZ= 2.09 (P= 0.04 ), WMD= 0.75 ( 0.07 , 1.43 )and at improving QOL.

• 通过比较用药前后6个判效指标；即国际前列腺症状评分(IPSS)、最大尿流率(MFR)、平均尿流率(AFR)、剩余尿量、生活质量(QOL)、前列腺体积的改善程度；发现在改善IPSS方面；坦索罗辛优于特拉唑嗪Z=2.；09(P=0